Replies to post #311 on Aratana Therapeutics Inc (fka PETX)

[SamSalters]

Yeah $35 million doesn't go far in the pharma research industry. If Galliprant was selling as well as it was being touted to they should have money rolling in. But it's not, sitting stagnant on shelves at the price point they have it at right now.